Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 7.94 as of 2026-09-25T21:56:23.881Z.
Consensus retrieved: 2026-09-10T03:52:23.809Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-25T21:56:23.881Z.
Quote observation: 2026-09-25T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1ac2d6789bc12d2e389645441bcd0ac8acc9d22d4e2b98c3fa13af0275b8988f
Forward PE Ratio (7.94) = Dated Quote Price ($178.86) / Consensus Forward EPS ($22.53)
FORWARD PE RATIO
7.94
SECTOR MEDIAN · HEALTHCARE
18.73
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-57.61%
vs the sector median at left
Universal Health Services, Inc.
Market Cap
$10.83B
Forward PE Ratio
7.94
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Universal Health Services, Inc. (UHS) | $10.83B | 7.94 |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 12.19 |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 13.00 |
| Bio-Techne Corporation (TECH)vs › | $11.37B | 35.33 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 39.52 |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 22.48 |
| DaVita Inc. (DVA)vs › | $11.46B | 12.02 |
| Globus Medical, Inc. (GMED)vs › | $10.05B | 14.90 |
| Molina Healthcare, Inc. (MOH)vs › | $9.96B | N/A |
| Henry Schein, Inc. (HSIC)vs › | $9.84B | 16.04 |
Trailing P/E
7.3
reported TTM EPS
Forward P/E
7.9
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $22.53 implies -7.6% EPS decline vs the reported trailing $24.38.
At the dated quote price of $178.86, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $22.53 | $22.03 – $23.06 | 12 | 7.9x |
| 2027-12-31 | $24.04 | $23.08 – $25.64 | 12 | 7.4x |
| 2028-12-31 | $26.58 | $24.32 – $28.33 | 9 | 6.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
